+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 45345

Chapter 45345 contains a list of PDF Full Texts available from EurekaMag.





Whicher, J.T., 1998:
BCR/IFCC reference material for plasma proteins (CRM 470). Community Bureau of Reference. International Federation of Clinical Chemistry

Sorscher, S.; Levonian, P., 1997:
BCRA 1 testing guidelines for high-risk patients

Norman, 1991:
BCS gap equations in the quantum limit

Ramakumar; Kumar; Jain; Chancey, 1993:
BCS pairing in a correlated narrow-band metal

Jankó; Smith; Ambegaokar, 1994:
BCS superconductivity with fixed number parity

Lal; Joshi, 1992:
BCS theory of superconductivity as modified by Coulomb interaction in cuprates

Weisz, 1993:
BCS theory of two-dimensional Landau-level superconductivity

Quick; Esebbag; de Llano M, 1993:
BCS theory tested in an exactly solvable fermion fluid

Appel; Fay, 1990:
BCS versus Josephson pair hopping between the CuO2 layers in high-Tc superconductors

Ohashi, Y.; Griffin, A., 2002:
BCS-BEC crossover in a gas of Fermi atoms with a Feshbach resonance

Casas; Getino; de Llano M; Puente; Quick; Rubio; van der Walt DM, 1994:
BCS-Bose model of exotic superconductors: Generalized coherence length

Hesper; Tjeng; Heeres; Sawatzky, 2000:
BCS-like density of states in superconducting A3C60 surfaces

Phillips, P.K.; Voak, D.; Whitton, C.M.; Downie, D.M.; Bebbington, C.; Campbell, J., 1993:
BCSH-NIBSC anti-D reference reagent for antiglobulin tests: the in-house assessment of red cell washing centrifuges and of operator variability in the detection of weak, macroscopic agglutination. British Committee for Standards in Haematology. National Institute for Biological Standards and Control

Skundrić, A.; Matić, S.; Odavić, M.; Lazić, Z., 1997:
BCT Implant System

Anonymous, 1999:
BCTP sounds its battle cry

Babu, Y.S.; Chand, P.; Bantia, S.; Kotian, P.; Dehghani, A.; El-Kattan, Y.; Lin, T.H.; Hutchison, T.L.; Elliott, A.J.; Parker, C.D.; Ananth, S.L.; Horn, L.L.; Laver, G.W.; Montgomery, J.A., 2000:
BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design

Roberts, J., 2000:
BDA accreditation causes concern

Ansorg, J., 2000:
BDC (Professional Society of German Surgeons) online. New internet presence of the professional society

Dzionek, A.; Fuchs, A.; Schmidt, P.; Cremer, S.; Zysk, M.; Miltenyi, S.; Buck, D.W.; Schmitz, J., 2000:
BDCA-2, BDCA-3, and BDCA-4: three markers for distinct subsets of dendritic cells in human peripheral blood

Schmidt, K., 2002:
BDI plans "general and family medicine". "Light" internist as better family physician

Anderssohn, M.D., 1993:
BDJ re-design

Fukumitsu, H.; Ohashi, A.; Nitta, A.; Nomoto, H.; Furukawa, S., 1998:
BDNF and NT-3 modulate expression and threonine phosphorylation of microtubule-associated protein 2 analogues, and alter their distribution in the developing rat cerebral cortex

Kobayashi, N.R.; Fan, D.P.; Giehl, K.M.; Bedard, A.M.; Wiegand, S.J.; Tetzlaff, W., 1998:
BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal regeneration

Reibel, S.; Depaulis, A.; Larmet, Y., 2001:
BDNF and epilepsy--the bad could turn out to be good

Bartrup, J.T.; Moorman, J.M.; Newberry, N.R., 1998:
BDNF enhances neuronal growth and synaptic activity in hippocampal cell cultures

Cohen-Cory, S.; Fraser, S.E., 1994:
BDNF in the development of the visual system of Xenopus

Klöcker, N.; Jung, M.; Stuermer, C.A.; Bähr, M., 2001:
BDNF increases the number of axotomized rat retinal ganglion cells expressing GAP-43, L1, and TAG-1 mRNA--a supportive role for nitric oxide?

Rivera, C.; Li, H.; Thomas-Crusells, J.; Lahtinen, H.; Viitanen, T.; Nanobashvili, A.; Kokaia, Z.; Airaksinen, M.S.; Voipio, J.; Kaila, K.; Saarma, M., 2002 :
BDNF-induced TrkB activation down-regulates the K+-Cl- cotransporter KCC2 and impairs neuronal Cl- extrusion

Frost, D.O., 2001:
BDNF/trkB signaling in the developmental sculpting of visual connections

Anonymous, 1999:
BDR erreicht ruckwirkende anderungen zu Angio/Interventionen

Jøsendal, O.; Aarø, L.Edvard., 2002:
BE smokeFREE--evaluation of an intervention program for smoke-free schools

Lund, K.Erik.; Lühr, E.; Jøsendal, O., 2002:
BE smokeFREE--from trials to national implementation

Diehl, V.; Franklin, J.; Hasenclever, D.; Tesch, H.; Pfreundschuh, M.; Lathan, B.; Paulus, U.; Sieber, M.; Rüffer, J.U.; Sextro, M.; Engert, A.; Wolf, J.; Hermann, R.; Holmer, L.; Stappert-Jahn, U.; Winnerlein-Trump, E.; Wulf, G.; Krause, S.; Glunz, A.; von Kalle, K.; Bischoff, H.; Haedicke, C.; Dühmke, E.; Georgii, A.; Loeffler, M., 1999:
BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group

Diehl, V.; Sieber, M.; Rüffer, U.; Lathan, B.; Hasenclever, D.; Pfreundschuh, M.; Loeffler, M.; Lieberz, D.; Koch, P.; Adler, M.; Tesch, H., 1997:
BEACOPP: an intensified chemotherapy regimen in advanced Hodgkin's disease. The German Hodgkin's Lymphoma Study Group

Cortelazzo, S.; Rossi, A.; Viero, P.; Bellavita, P.; Marchioli, R.; Marfisi, R.M.; Rambaldi, A.; Barbui, T., 1997:
BEAM chemotherapy and autologous haemopoietic progenitor cell transplantation as front-line therapy for high-risk patients with diffuse large cell lymphoma

Zeelenberg, C.; Kolitsi, Z.; Kapsalis, V.; Van Nimwegen, C.; Pallikarakis, N., 1996:
BEAM@Net: telematic services for clinical engineers and medical physicists

Worley, K.C.; Culpepper, P.; Wiese, B.A.; Smith, R.F., 1999:
BEAUTY-X: enhanced BLAST searches for DNA queries

Worley, K.C.; Wiese, B.A.; Smith, R.F., 1995:
BEAUTY: an enhanced BLAST-based search tool that integrates multiple biological information resources into sequence similarity search results

Arnold, P.; Moore, G., 2001:
BEC transition temperature of a dilute homogeneous imperfect Bose gas

Yoshino, G.; Hirano, T.; Kazumi, T., 2001:
BECAIT [Bezafibrate Coronary Atherosclerosis Intervention Trial]

Sinclair, J.A.; Oates, J.P.; Dale, R.G., 2000:
BED-time charts and their application to the problems of interruptions in external beam radiotherapy treatments

Gary, S.C.; Hockfield, S., 2001:
BEHAB/brevican: an extracellular matrix component associated with invasive glioma

Anonymous, 1999:
BELLE Newsletter

Martínez, G.; Tsuno, K., 2002:
BEM simulation of Wien filters

Anonymous, 1993:
BEMFAM delivers AIDS alert

Lowy, M.E.; Matyas, M.Lakes., 2002:
BEN portal--your doorway to a broader range of teaching material

Aoyagi, S.; Sugiyama, M.; Fukuda, H., 1998:
BEN1 and ZEN1 cDNAs encoding S1-type DNases that are associated with programmed cell death in plants

Kaina, B.; Ochs, K.; Grösch, S.; Fritz, G.; Lips, J.; Tomicic, M.; Dunkern, T.; Christmann, M., 2001:
BER, MGMT, and MMR in defense against alkylation-induced genotoxicity and apoptosis

Cryz, S.J., 1999:
BERNA: a century of immunobiological innovation

Hagemo, P.S., 1993:
BERTE--a database for children with congenital heart defects

Kumar, S.; Jayaraman, K.; Panchanathan, S.; Gurunathan, R.; Marti-Subirana, A.; Newfeld, S.J., 2003:
BEST: a novel computational approach for comparing gene expression patterns from early stages of Drosophila melanogaster development

Clausen; Fabricius, 2000:
BET Measurements: Outgassing of Minerals

Dib, K., 2000:
BETA 2 integrin signaling in leukocytes

Jain, A.K., 2000:
BETARU: an indigenously designed cordless stethoscope

Bradley, P.; Cowen, L.; Menke, M.; King, J.; Berger, B., 2001:
BETAWRAP: successful prediction of parallel beta -helices from primary sequence reveals an association with many microbial pathogens

Jonsson, S.Y.; Löfström, C.M.; Bäckvall, J.E., 2000:
BF(3)-Induced rearrangement of aziridino cyclopropanes derived from 2-phenylsulfonyl 1,3-dienes. Application to the total synthesis of (+/-)-ferruginine

Hardouin, C.; Taran, F.; Doris, E., 2001:
BF3*OET2-mediated rearrangement of cyclopropyl carbinols: a concise route to polycyclic cyclobutanes

Havlícek, V.; Jegorov, A.; Sedmera, P.; Ryska, M., 1995:
BF3-catalysed methanolysis combined with fast atom bombardment tandem mass spectrometry as a new tool for the preparation and analysis of linear secocyclosporins

Tamura, O.; Mitsuya, T.; Ishibashi, H., 2002:
BF3.OEt2-mediated cycloaddition of O-tert-butyldimethylsilyloximes having olefin moieties: intramolecular cycloaddition of N-borano-nitrones

Amorim; Barcelos-Neto, 1996:
BFF quantization of chiral-boson theories

Kumar, S., 1998:
BFHI: a step towards protecting fundamental rights of newborns

Aird, I.; Barratt, C.; Murdoch, A., 2002:
BFS Recommendations for Good Practice on the Screening of Egg and Embryo Donors

Nugent, D.; Hamilton, M.; Murdoch, A., 2002:
BFS Recommendations for Good Practice on the Storage of Ovarian and Prepubertal Testicular Tissue

Ye, X.; Zhu, J.; Wang, H., 2018:
Advances in quorum-sensing LuxR solos in bacteria

Fujiwara; Igarashi; Kuriki; Tabei, 1996:
BFV-BRST quantization of two-dimensional supergravity

Shimada, S.; Shiomori, K.; Honmyo, U.; Maeno, M.; Yagi, Y.; Ogawa, M., 2002:
BGP expression in gastric biopsies may predict the development of new lesions after local treatment for early gastric cancer

Barbosa, A.J.A.; Castro, L.P., 2002:
BGP expression in gastric epithelium and early gastric cancer

Huang, D.C.; Strasser, A., 2001:
BH3-Only proteins-essential initiators of apoptotic cell death

Sciuto, A.M.; Moran, T.S., 1999:
BHA diet enhances the survival of mice exposed to phosgene: the effect of BHA on glutathione levels in the lung

Deng, W.; Lin, S.H., 2018:
Advances in radiotherapy for esophageal cancer

Anonymous, 1982:
BHP to enforce staffing level requirements; half of HSAs may fold

Salter, H.; Zammit, L.; Horsburgh, T.; Drysdale, L., 2001:
BHP--a Broken Hill perspective

Huang, H.; Pan, X.; Zhou, J., 1999:
BHRF1 antisense oligonucleotide inhibits anti-apoptosis of nasopharyngeal carcinoma cells

Friedlander, R., 1993:
BHSM comes to the Flathead Indian Reservation

Metzner, M.; Hofmann, W.; Lessmann, H.W., 1993:
BHV-1 intradermal test in cattle

Rodilla, J.M.; De Mendonça, D.I.; Ismael, M.I.; Figueiredo, J.A.; Silva, M.L.; Lopes, E., 2002:
BI- and tricyclic diterpenoids from Halimium viscosum

Sitges-Serra, A.; Lobo, D.N., 2001:
BIA without measuring height: a one-wheeled bicycle

Nelson, R.W.; Jarvik, J.W.; Taillon, B.E.; Tubbs, K.A., 1999:
BIA/MS of epitope-tagged peptides directly from E. coli lysate: multiplex detection and protein identification at low-femtomole to subfemtomole levels

Vély, F.; Trautmann, A.; Vivier, E., 2000:
BIAcore analysis to test phosphopeptide-SH2 domain interactions

Dunea, 1999:
BIBA but LGFTD

Zelnio, R.N.; Gagnon, J.P.; Pashion, V.L., 1977:
BIBLIO: a reprint file management algorithm

Zhang, P.; Zheng, J.; Hexum, T.D., 1999:
BIBP 3226 inhibition of nicotinic receptor mediated chromaffin cell secretion

Mungall, D., 2002:
BIBR-1048 Boehringer Ingelheim

Buckley, A.W., 1985:
BIBS program helps families at risk of child abuse

Catán, F.; Uribe, M.; Carvajal, C.; Cavalleri, S.; Pizarro, F.; Uribe, J.P.; Uribe-Echevarría, S.; López, C.; Venegas, L., 2000:
BICAP tumor probe in the palliative treatment of malignant esophageal stenosis

Censor, Y.; Gordon, D.; Gordon, R., 2001:
BICAV: a block-iterative parallel algorithm for sparse systems with pixel-related weighting

Plesnila, N.; Zinkel, S.; Le, D.A.; Amin-Hanjani, S.; Wu, Y.; Qiu, J.; Chiarugi, A.; Thomas, S.S.; Kohane, D.S.; Korsmeyer, S.J.; Moskowitz, M.A., 2001:
BID mediates neuronal cell death after oxygen/ glucose deprivation and focal cerebral ischemia

Hamon, A.; Le Corronc, H.; Hue, B.; Rauh, J.J.; Sattelle, D.B., 1998:
BIDN, a bicyclic dinitrile convulsant, selectively blocks GABA-gated Cl- channels

Yoshihara, Y.; Kawasaki, M.; Tani, A.; Tamada, A.; Nagata, S.; Kagamiyama, H.; Mori, K., 1994:
BIG-1: a new TAG-1/F3-related member of the immunoglobulin superfamily with neurite outgrowth-promoting activity

Pacheco-Rodriguez, G.; Moss, J.; Vaughan, M., 2001:
BIG1 and BIG2: brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors

Kocak-Altintas, A.G.; Kocak-Midillioglu, I.; Akarsu, A.N.; Duman, S., 2001:
BIGH3 gene analysis in the differential diagnosis of corneal dystrophies

Kim, H.S.; Yoon, S.K.; Cho, B.J.; Kim, E.K.; Joo, C.K., 2001:
BIGH3 gene mutations and rapid detection in Korean patients with corneal dystrophy

Meythaler, J., 2003:
BIII-890-CL. Boehringer Ingelheim

Borsini, F.; Cesana, R.; Kelly, J.; Leonard, B.E.; McNamara, M.; Richards, J.; Seiden, L., 1998:
BIMT 17: a putative antidepressant with a fast onset of action?

Bader, G.D.; Donaldson, I.; Wolting, C.; Ouellette, B.F.; Pawson, T.; Hogue, C.W., 2000:
BIND--The Biomolecular Interaction Network Database

Bader, G.D.; Hogue, C.W., 2000:
BIND--a data specification for storing and describing biomolecular interactions, molecular complexes and pathways

Reetz, M.T.; Moulin, D.; Gosberg, A., 2001:
BINOL-based diphosphonites as ligands in the asymmetric Rh-catalyzed conjugate addition of arylboronic acids

Moore, D.; Pu, L., 2002:
BINOL-catalyzed highly enantioselective terminal alkyne additions to aromatic aldehydes

DiMauro, E.F.; Kozlowski, M.C., 2001:
BINOL-salen metal catalysts incorporating a bifunctional design

Casas, Jús.; Nájera, C.; Sansano, Jé.M.; Saá, Jé.M., 2002:
BINOLAM, a recoverable chiral ligand for bifunctional enantioselective catalysis: the asymmetric synthesis of cyanohydrins

Schlegel, A.K.; Donath, K., 1997:
BIO-OSS--a resorbable bone substitute?

Rone, R., 2000:
BIO2000. Biotechnology Industry Organization Conference. Boston, Massachusetts, USA. March 26-30, 2000

Van Camp, A.J., 1992:
BIOETHICSLINE and other sources of ethics information

Darragh, M., 2001:
BIOETHICSLINE on the World Wide Web

Dorsch, J.L., 1997:
BIOETHICSLINE use by medical students: curriculum-integrated instruction and collection development implications

Kahn, T.J.; Orr, C., 1985:
BIOETHICSLINE: an overview for searchers

Mann, J.; Ramakrishna, R.; Magge, R.; Wernicke, A.Gabriella., 2018:
Advances in Radiotherapy for Glioblastoma

Anonymous, 2002:
BIOLASE and UCLA successfully complete first Waterlase sinus surgery in the United States

Anonymous, 2002:
BIOLASE receives first-ever FDA clearance for complete laser root canal therapy

Ni, J., 2002:
BIOME 6000 Project: latest advances of reconstructing palaeobiome

Lucio, P.; Gaipa, G.; van Lochem, E.G.; van Wering, E.R.; Porwit-MacDonald, A.; Faria, T.; Bjorklund, E.; Biondi, A.; van den Beemd, M.W.; Baars, E.; Vidriales, B.; Parreira, A.; van Dongen, J.J.; San Miguel, J.F.; Orfao, A., 2001:
BIOMED-I concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings. BIOMED-1 Concerted Action Investigation of Minimal Residual Disease in Acute Leukemia: International Standardization and Clinical Evaluation

Scheepers, P.T.J.; Coggon, D.; Knudsen, L.E.; Anzion, R.; Autrup, H.; Bogovski, S.; Bos, R.P.; Dahmann, D.; Farmer, P.; Martin, E.A.; Micka, V.; Muzyka, V.; Neumann, H.G.; Poole, J.; Schmidt-Ott, A.; Seiler, F.; Volf, J.; Zwirner-Baier, I., 2002:
BIOMarkers for occupational diesel exhaust exposure monitoring (BIOMODEM)--a study in underground mining

Sanchez-Nieto, B.; Nahum, A.E., 2000:
BIOPLAN: software for the biological evaluation of. Radiotherapy treatment plans

Bartsev, S.I.; Mezhevikin, V.V.; Okhonin, V.A., 1996:
BIOS-4 as an embodiment of CELSS development conception

O'Sullivan, C.; Alcock, S.J., 2001:
BIOSET: Biosensors for Environmental Technology EU Workshop 'Biosensors for Environmental Monitoring: Technology Evaluation'. Held in Kinsale, Ireland, 12-15 May 1998

Prasek, M.A., 1999:
BIOSIS previews: the power of codes

Kirmse, M.; Bremer, F., 2001:
BIPAP--a forward-looking ventilation mode? Contra

Silver, M.R., 1998:
BIPAP: useful new modality or confusing acronym?

Harboe, S.; Söreide, E., 2000:
BIPAP: useful new modality?

Imison, A., 2000:
BIPP aspiration

Lillicrap, S.C., 1993:
BIR presidential address: exploring the niches

Hately, W., 1993:
BIR presidential address: the challenge of change

Mondello, E.; Panasiti, R.; Siliotti, R.; Floridia, D.; David, A.; Trimarchi, G., 2002:
BIS and Ramsay score in critically ill patient: what future?

Yamaguchi, F.; Oi, Y.; Aoki, W.; Nakamura, R.; Igarashi, A.; Kubota, M.; Sawada, K.; Shimura, T.; Takahashi, H.; Kobayashi, S.; Teramoto, A., 2002:
BIS monitoring is useful for reliable intraoperative cortical mapping during brain tumor operations

Mérat, S.; Lévecque, J.P.; Le Gulluche, Y.; Diraison, Y.; Brinquin, L.; Hoffmann, J.J., 2001:
BIS monitoring may allow the detection of severe cerebral ischemia

Spackman, T.N.; Abel, M.D., 2001:
BIS monitoring: there's more to it than awareness

Parisi, A.; Bartolazzi, A.; Bonino, C.; Camagna, M.; DeMonte, L.B.; Lombardi, A.; Natali, P.G.; Paganelli, G.; Tarditi, L.; Vassarotto, C., 1993:
BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy

Ohnishi, H.; Kubota, M.; Sano, S., 1997:
BIT (Bit) maps to mouse chromosome 2

Gibbons, R.W.; Palmer, B.J., 1994:
BJ in 1906: predictions and personal reflections

Stare, J.; Harrell, F.E.; Heinzl, H., 2000:
BJ: an S-Plus program to fit linear regression models to censored data using the Buckley-James method

Hall, G.M., 1998:
BJA citation classics 1945-1992

Smith, G., 2001:
BJA concise - a step too far

Scott, L., 1995:
BJC Health System expands its reach

Matheny, M., 1996:
BJC Health System: the perils of a proactive strategy

Moore, J.D., 1999:
BJC chief to step down. Brown will resign to focus on AHA chairman post

Scott, L., 1994:
BJC to reorganize services

Anonymous, 1996:
BJN survey reveals that 30% of nurses take on extra work to pay the bills

Anonymous, 1995:
BJO directory of orthodontic organisations

Webb, 2000:
BJS and the blitz

Murie; Farndon, 1999:
BJS in the new millennium

Nickel, 2000:
BJU international volume 85, number 2, january 2000 european urology update series 2000:1 prostatitis: lessons from the 20th century

Ransom, C.B.; Liu, X.; Sontheimer, H., 2002:
BK channels in human glioma cells have enhanced calcium sensitivity

Tanaka, Y.; Horinouchi, T.; Tanaka, H.; Shigenobu, K.; Koike, K., 2002:
BK channels play an important role as a negative feedback mechanism in the regulation of spontaneous rhythmic contraction of urinary bladder smooth muscles

Garavelli, P.Luigi.; Boldorini, R., 2002:
BK virus encephalitis in an HIV-seropositive patient. Preliminary data

Lin, P.L.; Vats, A.N.; Green, M., 2001 :
BK virus infection in renal transplant recipients

Fishman, J.A., 2002:
BK virus nephropathy--polyomavirus adding insult to injury

Stoner, G.L.; Alappan, R.; Jobes, D.V.; Ryschkewitsch, C.F.; Landry, M.L., 2002:
BK virus regulatory region rearrangements in brain and cerebrospinal fluid from a leukemia patient with tubulointerstitial nephritis and meningoencephalitis

Bachman, D.M., 1999:
BK virus retinitis

Iwamoto, S.; Azuma, E.; Hori, H.; Hirayama, M.; Kobayashi, M.; Komada, Y.; Nishimori, H.; Miyahara, M., 2002:
BK virus-associated fatal renal failure following late-onset hemorrhagic cystitis in an unrelated bone marrow transplantation

Petrogiannis-Haliotis, T.; Sakoulas, G.; Kirby, J.; Koralnik, I.J.; Dvorak, A.M.; Monahan-Earley, R.; DE Girolami, P.C.; DE Girolami, U.; Upton, M.; Major, E.O.; Pfister, L.A.; Joseph, J.T., 2001:
BK-related polyomavirus vasculopathy in a renal-transplant recipient

Benvenisty, N.; Ornitz, D.M., 1995:
BK1: an FGF-responsive central nervous system-derived cell line

Suyono, H., 1989:
BKKBN and the expanding role of private sector FP services and commercial contraceptive sales in Indonesia

Gaëta, B., 2000:
BLAST ... what next?

Boone, M.; Upton, C., 2001:
BLAST Search Updater: a notification system for new database matches

Mullan, L.J.; Williams, G.W., 2002:
BLAST and go?

Gaëta, B.A., 2000:
BLAST on the Web

Kent, W.James., 2002:
BLAT--the BLAST-like alignment tool

Soussi, T., 2001:
BLM (RCQL2) or Bloom Syndrome

Ishiai, M.; Kurosaki, M.; Pappu, R.; Okawa, K.; Ronko, I.; Fu, C.; Shibata, M.; Iwamatsu, A.; Chan, A.C.; Kurosaki, T., 1999:
BLNK required for coupling Syk to PLC gamma 2 and Rac1-JNK in B cells

Ciafaloni, M.; Ciafaloni, P.; Comelli, D., 2001:
BLOCH-Nordsieck violation in spontaneously broken Abelian theories

Spoor, J.E., 1982:
BLS (basic life support) is not enough

Root, N.; Sebastian, D., 1981:
BLS develops measure of job risk by occupation

Skoog, A.I., 1984:
BLSS: a contribution to future life support

Annest, J.L.; Mahaffey, K.R.; Cox, D.H.; Roberts, J., 1982:
BLood lead levels for persons 6 months-74 years of age: United States, 1976-80

Zhou, T.; Zhang, J.; Carter, R.; Kimberly, R., 2002:
BLyS and B cell autoimmunity

Dogné, J.M.; Neven, P.; Damas, J.; Fontaine, J.; Rolin, S.; De Leval, X.; Delarge, J.; Masereel, B., 1999:
BM 144: an original thromboxane A2 receptor antagonist derived from torasemide

Krause, D.S., 2003:
BM-derived stem cells for the treatment of nonhematopoietic diseases

Valle, P.C.; Dybdahl, J.H., 1998:
BM-test Colon Albumin for determination of fecal occult blood. On what reasons was the refusion by the Risktrygdeverket based?

Beecham, L., 2000:
BMA accused of contempt of court

Ashraf, H., 2001:
BMA address the issue of withholding and withdrawing treatment

Anonymous, 1987:
BMA agrees on joint statement on AIDS with DHSS; BMA's AIDS working party

Dean, M., 2000:
BMA and NICE under attack over family doctor's targets. British Medical Association. National Institute for Clinical Excellence

Anonymous, 1998:
BMA and health minister will discuss review body remit

Edwards, R., 1985:
BMA apologises to Mr. Robert Edwards

Moore, R.A.; McQuay, H.J.; Oldman, A.D.; Smith, L.E., 2000:
BMA approves acupuncture. BMA report is wrong

Kovacs, F.M.; Gil del Real, M.T., 2000:
BMA approves acupuncture. Is approval of acupuncture for back pain really evidence based?

Fordham, S., 1997:
BMA asks for 53% pay increase. General practitioners want parity with hospital consultants

Joseph, A.E., 1997:
BMA asks for 53% pay increase. Morality of such claims is doubtful in light of growing disparity in society

Ferriman, 1999:
BMA backs junior doctors' fight against government

Anonymous, 2003:
BMA calls for ban on smoking in public places

Woodman, R., 1999:
BMA calls for extra safeguards for life and death decisions

Anonymous, 1999:
BMA calls for guidelines on new and expensive drugs

Burke, 1999:
BMA calls for independent commissioner on child health

Anonymous, 1999:
BMA calls for renewed action on debt relief

Anonymous, 1998:
BMA calls for risk management approach to stress

Beecham, L., 1998:
BMA calls for smoking to be banned in public places

Hughes, 1998:
BMA cannot bring proceedings arising out of incidents in other countries

Anonymous, 1999:
BMA chairman warns of fight ahead

Xu, Z-hong.; Huang, W.; Lin, D.; Ge, X-song.; Lin, X-liang.; Feng, S-yuan.; Li, Y-zeng.; Chen, R., 2018:
Advances in Raman Spectroscopy for Nasopharyngeal Carcinoma Tissue

Anonymous, 1998:
BMA council agrees structure for devolution

Anonymous, 2000:
BMA criticises benefits agency work

Warden, J., 1995:
BMA criticises guidance on long term care

Morant, H., 2000:
BMA demands more responsible media attitude on body image

Jessiman, I.M., 1996:
BMA division disagrees with association's stance over advance directives

Anonymous, 1982:
BMA draws up code for doctors

Anonymous, 1999:
BMA ends link with healthcall

Anonymous, 1999:
BMA establishes racial equality committee

Richmond, C., 2000:
BMA gives thumbs down to regulatory body

Anonymous, 1988:
BMA guidelines on the use of fetal tissue

Dyer, C., 2002:
BMA has to pay 815000 pounds sterling in damages for indirect racial discrimination

Anonymous, 1999:
BMA hopes for at least 10% pay rise

Craft, N., 1996:
BMA issues new guidance on surrogacy

Anonymous, 1999:
BMA launches consultation on helsinki declaration

Ferriman, A., 2000:
BMA launches review on UK healthcare spending

Dobson, R., 2001:
BMA may seek legal challenge over curbs on private practice

Redgrave, P.; Waller, J., 1998:
BMA must voice its opposition to Cuban embargo

Moore, W., 2002:
BMA negotiator calls for more male medical students

Anonymous, 1998:
BMA notice

Woodman, R., 1999:
BMA opens door on human reproductive cloning

Beecham, L., 1997:
BMA opposes legalisation of euthanasia

Grabham, T., 2002:
BMA president clarifies his message

Smith, R., 2001:
BMA president warns doctors not to take public esteem for granted

Scott, H., 2002:
BMA proposes radical changes to the nursing role

Fricker, J., 1999:
BMA proposes strategy to reformulate waiting lists

Beecham, L., 2001:
BMA remains concerned about GMC structure

Anonymous, 2000:
BMA responds to proposals on the GMC

Beecham, L., 1994:
BMA says fetal tissue should not be used for treatment

Beecham, L., 1993:
BMA says no to mandatory HIV testing

Eaton, 2002:
BMA says world is ill prepared for bioterrorism

Beecham, L., 2000:
BMA secretary to be Scottish CMO

Yates, J., 1996:
BMA should look at inequalities in the NHS

Anonymous, 1999:
BMA starts debate on presumed organ donation

Anonymous, 2000:
BMA starts healthcare funding review

Gulland, A., 2002:
BMA steps up call for ban on smoking in public places

Beecham, L., 2001:
BMA supports GPs' quest for new contract

Anonymous, 2000:
BMA supports medical majority on GMC

Beecham, L., 2001:
BMA to consult on withdrawing treatment

Mayor, S., 1997:
BMA wants licensing of cannabis to be changed

Anonymous, 2000:
BMA wants open debate on regulation of doctors

Beecham, L., 1999:
BMA wants presumed consent for organ donors

Beecham, 1999:
BMA welcomes plans to regulate private care

Dyer, C., 1996:
BMA will review guidelines on PVS

Beecham, 2000:
BMA's annual meeting expresses "no confidence" in GMC

Anonymous, 1998:
BMA's counselling service takes over 6000 calls

Miller, D.L.; Frankland, L., 1993:
BMA's evidence on specialist training

Lewin, S.; de Gruchy, J., 1999:
BMA's gold medal award to the president of the South African Medical association. Is this a travesty?

Dyer, C., 1999:
BMA's patient confidentiality rules are deemed unlawful

Rosenberg, M., 1995:
BMA's representation of clinical and medical directors. Medical directors in Wales not represented

Ikeda, M., 2001:
BMAL1 and circadian rhythm

Tang, D.G.; Li, L.; Zhu, Z.; Joshi, B.; Johnson, C.R.; Marnett, L.J.; Honn, K.V.; Crissman, J.D.; Krajewski, S.; Reed, J.C.; Timar, J.; Porter, A.T., 1998:
BMD188, A novel hydroxamic acid compound, demonstrates potent anti-prostate cancer effects in vitro and in vivo by inducing apoptosis: requirements for mitochondria, reactive oxygen species, and proteases

Armstrong, P.W.; Hughes, V.M., 1998:
BME defines public policy in physician self-referral

Purohit, T.J.; Hanning, S.M.; Wu, Z., 2018:
Advances in rectal drug delivery systems

Bassingthwaighte, J.B., 1994:
BMES's involvement in consortia of scientific societies

Russell, D.H., 1996:
BMETs in equipment repair depots: does the need remain?

Zerbo, D.; Flezar, M.; Stefancic, M., 1999:
BMI and Heath-Carter somatotypes of female students in Ljubljana

Seidman, D.S., 1993:
BMI and duration of breast feeding

Luciano, A.; Piccoli, A.; Bonetti, P.; Romano, R.; Bolognani, M.; Castellarin, A.; Zoppi, G., 2001:
BMI centile as an indicator of degree of obesity in childhood

Petersen, T.Anne-Grete.; Rasmussen, Søren.; Madsen, M., 2002:
BMI of Danish school children measured during the periods 1986/1987--1996/1997 compared to Danish measurement in 1971/1972

Johnson, M., 2002:
BMI--another "vital" sign?

Widhalm, K.; Schönegger, K., 1999:
BMI: does it really reflect body fat mass?

De Geeter, F., 1997 :
BMIPP and flow tracers in myocardial hypoperfusion

Tadamura, E.; Tamaki, N.; Kudoh, T.; Hattori, N.; Konishi, J., 1999:
BMIPP compared with PET metabolism

Taki, J.; Matsunari, I.; Nakajima, K.; Tonami, N., 1999:
BMIPP compared with thallium redistribution

Franken, P.R.; Hambÿe, A.S.; De Geeter, F.W., 1999:
BMIPP imaging to assess functional outcome in patients with acute and chronic left ventricular dysfunction

Nishimura, S.; Ohta, Y., 1999:
BMIPP in angina pectoris

Knapp, F.F.; Kropp, J., 1999:
BMIPP-design and development

Briffa, E.; Abbasi, K., 2003:
BMJ Learning

Smith, 1998:
BMJ bans anniversaries. We promise our readers no more boring anniversaries

Davis, R.M.; Pless, B., 2001:
BMJ bans "accidents"

Anonymous, 1998:
BMJ data

Badrinath, P., 1998:
BMJ has largely met its target for publication time for long papers

McConnell, J., 1999 :
BMJ introduces a fast track system for papers. Publication cycle

Goldbeck-Wood; Robinson, 1999:
BMJ introduces a fast track system for papers. We will offer to publish exceptional papers within four weeks

Thulesius, H., 2000:
BMJ is not on the impact factor list

Smith, R.; Williamson, A., 2002:
BMJ journals free to the developing world

Wahal, C.; Kumar, A.; Pyati, S., 2018:
Advances in regional anaesthesia: A review of current practice, newer techniques and outcomes

Delamothe, T., 2000:
BMJ set to sign with PubMed Central, JSTOR, and WorldSpace

Kerr, M., 1999:
BMJ should cover health policies of all parties in Scottish election

Morris, 1999:
BMJ should stop confusing its readers over national differences

Abbasi, K., 2001:
BMJ to act on media abuse

Ferriman, 2000:
BMJ wins an Ig nobel prize

Mihill, C.; Pope, N.; Hunt, L.; Cooper, G.; Fletcher, D., 1996:
BMJ's embargo should not be broken

Horgan, A., 2002:
BMJ's impact factor increases by 24%

Tobias, J.S., 1997:
BMJ's present policy (sometimes approving research in which patients have not given fully informed consent) is wholly correct

Southall, D., 1993:
BMJ's press release inaccurate

Anonymous, 2002:
BMP 2--Genetics Institute/ Medtronic-Sofamor Danek/Integra. Bone morphogenetic protein 2--Genetics Institute/ Medtronic-Sofamor Danek/Integra, INFUSE Bone Graft, recombinant human bone morphogenetic protein 2--Genetics Institute/Medtronic-Sofamor Danek/Integra, RhBMP 2--Genetics Institute/Medtronic-Sofamor Danek/Integra

Anonymous, 1997:
BMP approach deters mental illness treatment

Sigel, M.E., 1994:
BMP just following the law

Cheifetz, S., 2000:
BMP receptors in limb and tooth formation

Nachaliel, N.; Re'Em-Kalma, Y.; Eshed, O.; Elias, S.; Frank, D., 1999:
BMP regulates vegetal pole induction centres in early xenopus development

Délot, Eèle.C.; Bahamonde, M.E.; Zhao, M.; Lyons, K.M., 2002:
BMP signaling is required for septation of the outflow tract of the mammalian heart

Bessho, K.; Carnes, D.L.; Cavin, R.; Chen, H.Y.; Ong, J.L., 1999:
BMP stimulation of bone response adjacent to titanium implants in vivo

Majumdar, M.K.; Wang, E.; Morris, E.A., 2001:
BMP-2 and BMP-9 promotes chondrogenic differentiation of human multipotential mesenchymal cells and overcomes the inhibitory effect of IL-1

Piscione, T.D.; Yager, T.D.; Gupta, I.R.; Grinfeld, B.; Pei, Y.; Attisano, L.; Wrana, J.L.; Rosenblum, N.D., 1998:
BMP-2 and OP-1 exert direct and opposite effects on renal branching morphogenesis

Hanada, K.; Solchaga, L.A.; Caplan, A.I.; Hering, T.M.; Goldberg, V.M.; Yoo, J.U.; Johnstone, B., 2001:
BMP-2 induction and TGF-beta 1 modulation of rat periosteal cell chondrogenesis

Mayr-Wohlfart, U.; Kessler, S.; Knöchel, W.; Puhl, W.; Günther, K.P., 2001:
BMP-4 of Xenopus laevis stimulates differentiation of human primary osteoblast-like cells

Boskey, A.L.; Paschalis, E.P.; Binderman, I.; Doty, S.B., 2002:
BMP-6 accelerates both chondrogenesis and mineral maturation in differentiating chick limb-bud mesenchymal cell cultures

Francis-West, P.H.; Parish, J.; Lee, K.; Archer, C.W., 1999:
BMP/GDF-signalling interactions during synovial joint development

Bahamonde, M.E.; Lyons, K.M., 2001:
BMP3: to be or not to be a BMP

Wright, V.; Peng, H.; Usas, A.; Young, B.; Gearhart, B.; Cummins, J.; Huard, J., 2002:
BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice

Machado, R.D.; Pauciulo, M.W.; Thomson, J.R.; Lane, K.B.; Morgan, N.V.; Wheeler, L.; Phillips, J.A.; Newman, J.; Williams, D.; Galiè, N.; Manes, A.; McNeil, K.; Yacoub, M.; Mikhail, G.; Rogers, P.; Corris, P.; Humbert, M.; Donnai, D.; Martensson, G.; Tranebjaerg, L.; Loyd, J.E.; Trembath, R.C.; Nichols, W.C., 2000:
BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension

Lane, J.M., 2001:
BMPs: why are they not in everyday use?

Mathers, J.C., 1998:
BMR multiples as a basis for estimating energy needs

Hobman, J.L., 2001:
BMRI-2, Rossendorf/Dresden, Germany (30 August - 1 September 2000)

Anonymous, 1994:
BMS (Bristol's Southmead Hospital) allows fewer to manage more while using less

Anonymous, 2002:
BMS and Exelixis target tumor suppression pathways

Hulpke-Wette, M.; Buchhorn, R., 2002:
BMS-193884 and BMS-207940 Bristol-Myers Squibb

Mackay, K.B., 2001:
BMS-204352 (Bristol Myers Squibb)

Witherell, G., 2001:
BMS-232632 (Novartis/Bristol-Myers Squibb)

Gaylord, G., 2002:
BMS-232632, a new protease inhibitor, is taken once daily

Lee, F.Y.; Borzilleri, R.; Fairchild, C.R.; Kim, S.H.; Long, B.H.; Reventos-Suarez, C.; Vite, G.D.; Rose, W.C.; Kramer, R.A., 2001:
BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy

Poulaki, V., 2002:
BMS-275291. Bristol-Myers Squibb

Burke, J.R.; Pattoli, M.A.; Gregor, K.R.; Brassil, P.J.; MacMaster, J.F.; McIntyre, K.W.; Yang, X.; Iotzova, V.S.; Clarke, W.; Strnad, J.; Qiu, Y.; Zusi, F.Christopher., 2002:
BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice

Gordon, K.A.; Pfaller, M.A.; Jones, R.N., 2002:
BMS284756 (formerly T-3811, a des-fluoroquinolone) potency and spectrum tested against over 10,000 bacterial bloodstream infection isolates from the SENTRY antimicrobial surveillance programme (2000)

Sardella, A.; Carrassi, A., 2001:
BMS: S for syndrome or S for symptom? A reappraisal of the burning mouth syndrome

Hoogerbrugge, P.M.; Vossen, J.M., 1995:
BMT for isolated central nervous system relapse in children with ALL

Burt, R.K., 1997:
BMT for severe autoimmune diseases: an idea whose time has come

Ladenstein, R.; Peters, C.; Matthes-Martin, S.; Rosenmayr, A.; Höcker, P.; Pötter, R.; Pötschinger, U.; Gadner, H., 1996:
BMT from unrelated (UD) or family donors other than HLA identical siblings (FDNS), GVHD prophylaxis, incidence and treatment

Busca, A.; Uderzo, C., 2001:
BMT: Bone Marrow Transplant Associated Thrombotic Microangiopathy

Tremblay, G., 2000:
BN 52021 decreases alveolar macrophage-mediated lung injury in experimental extrinsic allergic alveolitis

Grino, J.M., 1994:
BN 52021: a platelet activating factor antagonist for preventing post-transplant renal failure. A double-blind, randomized study. The BN 52021 Study Group in Renal Transplantation

Chen, Z.; Jiao, H.; Hirsch, A.; Thiel, W., 2001:
BN-doped fullerenes: an NICS characterization

Debek, W.; Chyczewski, L.; Oldhafer, K.J., 2000:
BN52021 inhibits activation of peritoneal mast cells caused by hemorrhage and blood volume restoration

Anonymous, 1978:
BNA survey: firms expand benefits, reject national health

Imanishi, T.; Obika, S., 2002:
BNAs: novel nucleic acid analogs with a bridged sugar moiety

Lüdemann, L.; Matzen, T.; Schmidt, R.; Scobel, W., 1996:
BNCT as a boost for fast neutron therapy?

Henriksson, R.; Persson, L., 2002:
BNCT--neutron radiotherapy of brain tumors

Anonymous, 2002:
BNE acts on recommendations of competency/jurisprudence task forces

Anonymous, 2002:
BNE proposes revised delegation rules

Baker, R., 1994:
BNHS (British National Health Service) age rationing: a riposte to Bates

Lowenstein, D.I.; Lowenstein, D.I., 2002:
BNL accelerator-based radiobiology facilities

Hart, G.; Jarritt, P.; Cosgriff, P., 1997:
BNMS gamma camera/data processor system specification questionnaire

Bruneau, B.G.; Piazza, L.A.; de Bold, A.J., 1998:
BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria

Burger, M.R.; Burger, A.J., 2002:
BNP in decompensated heart failure: diagnostic, prognostic and therapeutic potential

Lader, E., 2003:
BNP levels had high sensitivity but moderate specificity for detecting congestive heart failure in the emergency department

Grantham, J.A.; Burnett, J.C., 1997:
BNP: increasing importance in the pathophysiology and diagnosis of congestive heart failure

Cowie, M.R., 2000:
BNP: soon to become a routine measure in the care of patients with heart failure?

Wiersbitzky, S.; Burtzlaff, C.; Weinke, I.; Wiersbitzky, H.; Herrmann, H., 1993:
BNS epilepsy after the second triple (DPT) vaccination?

Kõks, S.; Soosaar, A.; Võikar, V.; Bourin, M.; Vasar, E., 2000:
BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze

Ketter, J., 1994:
BOD approves plan to increase staff RN participation. As I see it

Taylor, N.J.; Baddeley, H.; Goodchild, K.A.; Powell, M.E.; Thoumine, M.; Culver, L.A.; Stirling, J.J.; Saunders, M.I.; Hoskin, P.J.; Phillips, H.; Padhani, A.R.; Griffiths, J.R., 2001:
BOLD MRI of human tumor oxygenation during carbogen breathing

Dunn, J.F.; Zaim-Wadghiri, Y.; Pogue, B.W.; Kida, I., 1999:
BOLD MRI vs. NIR spectrophotometry. Will the best technique come forward?

Landuyt, W.; Hermans, R.; Bosmans, H.; Sunaert, S.; Béatse, E.; Farina, D.; Meijerink, M.; Zhang, H.; Van Den Bogaert, W.; Lambin, P.; Marchal, G., 2001:
BOLD contrast fMRI of whole rodent tumour during air or carbogen breathing using echo-planar imaging at 1.5 T

Nakai, T.; Matsuo, K.; Kato, C.; Okada, T.; Moriya, T.; Isoda, H.; Takehara, Y.; Sakahara, H., 2001:
BOLD contrast on a 3 T magnet: detectability of the motor areas

Mohamed, F.B.; Pinus, A.B.; Faro, S.H.; Patel, D.; Tracy, J.I., 2002:
BOLD fMRI of the visual cortex: quantitative responses measured with a graded stimulus at 1.5 Tesla

Nakada, T., 1999:
BOLD functional MRI: practical pitfalls

Song, A.W.; Fichtenholtz, H.; Woldorff, M., 2002:
BOLD signal compartmentalization based on the apparent diffusion coefficient

Nathan, F.E.; Berd, D.; Sato, T.; Shield, J.A.; Shields, C.L.; De Potter, P.; Mastrangelo, M.J., 1997:
BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy

Wacker, C.M.; Bock, M.; Hartlep, A.W.; Bauer, W.R.; van Kaick, G.; Pfleger, S.; Ertl, G.; Schad, L.R., 1999:
BOLD-MRI in ten patients with coronary artery disease: evidence for imaging of capillary recruitment in myocardium supplied by the stenotic artery

Bohning, D.E.; Shastri, A.; Wassermann, E.M.; Ziemann, U.; Lorberbaum, J.P.; Nahas, Z.; Lomarev, M.P.; George, M.S., 2000:
BOLD-f MRI response to single-pulse transcranial magnetic stimulation (TMS)

Wilkinson, R.M., 1998:
BOMB! Making a difference during a hospital emergency

Germà-Lluch, J.R.; Garcia del Muro, X.; Tabernero, J.M.; Sánchez, M.; Aparicio, J.; Alba, E.; Barnadas, A., 1999:
BOMP/EPI intensive alternating chemotherapy for IGCCC poor-prognosis germ-cell tumors: the Spanish Germ-Cell Cancer Group experience (GG)

Johnson, C.; Macaluso, M., 1999:
BONENT to offer certification for LPNs, LVNs in nephrology

Cosgrove, D.A.; Kenny, P.W., 1996:
BOOMSLANG: a program for combinatorial structure generation

Verberckmoes, R.; Verbeken, E.; Verschakelen, J.; Vanrenterghem, Y., 1996:
BOOP (bronchiolitis obliterans organizing pneumonia) after renal transplantation

Gupta, P.R.; Joshi, N.; Khangarot, S., 2000:
BOOP presenting as pseudo-lymphadenopathy

Zhu, Q.; Chen, D., 2017:
Advances in relationship between PTEN and myocardial fibrosis

Belykh, S.I., 1994:
BOP-polymer implants for fixation of tubular bones and replacement of osseous tissue defects

Taigman, M.; Forster, J., 2002:
BORSTAR: border patrol EMS

Gyarmati, G.; Kadoya, H.; Moon, J-Young.; Burford, J.L.; Ahmadi, N.; Gill, I.S.; Hong, Y-Kwon.; Dér, Bálint.; Peti-Peterdi, János., 2018:
Advances in Renal Cell Imaging

Fishman, L.M.; Anderson, C.; Rosner, B., 2002:
BOTOX and physical therapy in the treatment of piriformis syndrome

Carruthers, J.; Carruthers, A., 2001:
BOTOX use in the mid and lower face and neck

Mendez-Eastman, S.K., 2002:
BOTOX: a review

Anonymous, 1998:
BP and weight

Scribner, B.H., 2000:
BP control, dialysis adequacy, and vitamin C

Anonymous, 2002:
BP drug approved for heart failure

Robischon, T., 1983:
BP monitoring on the move

Preti, A., 2001:
BP-897 Bioprojet

Nelson, D.; Mayo, R.; Moody, P.E., 2001:
BP: developing excellence in the global enterprise

Seiwerth, S.; Sikiric, P.; Grabarevic, Z.; Zoricic, I.; Hanzevacki, M.; Ljubanovic, D.; Coric, V.; Konjevoda, P.; Petek, M.; Rucman, R.; Turkovic, B.; Perovic, D.; Mikus, D.; Jandrijevic, S.; Medvidovic, M.; Tadic, T.; Romac, B.; Kos, J.; Peric, J.; Kolega, Z., 1997 :
BPC 157's effect on healing

Maguire, D.; Power, C.; McAnena, O.J., 2000:
BPCF vs HCF

Lombardo, G.T., 1997:
BPD and ADHD

Scopinaro, 2000:
BPD and prader willi syndrome

Anonymous, 1999:
BPH survey reveals confusion about condition that strikes 80% of men by age 80

Knutson, T.; Edlund, C.; Fall, M.; Dahlstrand, C., 2001:
BPH with coexisting overactive bladder dysfunction--an everyday urological dilemma

McConnell, J.D.; Goldwasser, B.; Marberger, M., 1995:
BPH: what really works?

Kumararatne, D.S., 2000:
BPL plasma products: new source, enhanced products

Hoffer, A., 2003:
BPM: antidote to inefficiency. Business process management serves as a foundation for effective workflow automation in healthcare

Watson, M.S., 2001:
BPMC drops hCG patent infringement lawsuit against Kaiser

Jerva, M., 2001:
BPR (business process redesign) and systems analysis and design: making the case for integration

Silverstein, M.L.; Mavrolefteros, G.; Close, D., 1997:
BPRS syndrome scales during the course of an episode of psychiatric illness

Landis, N.T., 2000:
BPS roster of certified pharmacists nears 3000 mark

Bandos, I.A.; de Azcárraga, J.A.; Izquierdo, J.M.; Lukierski, J., 2001:
BPS states in M theory and twistorial constituents

Anonymous, 1997:
BPS, others ponder high failure rate on pharmacotherapy exam

Grouazel, S.; Perez, J.; Astier, J.P.; Bonneté, F.; Veesler, S., 2002:
BPTI liquid-liquid phase separation monitored by light and small angle X-ray scattering

Büyükgebiz, O.; Aktan, A.O.; Haklar, G.; Yalçin, A.S.; Yeğen, C.; Yalin, R.; Ercan, Z.S., 1996:
BQ-123, a specific endothelin (ETA) receptor antagonist, prevents ischemia-reperfusion injury in kidney transplantation

Zamora, M.A.; Dempsey, E.C.; Walchak, S.J.; Stelzner, T.J., 1993:
BQ123, an ETA receptor antagonist, inhibits endothelin-1-mediated proliferation of human pulmonary artery smooth muscle cells

Koyama, Y.; Takemura, M.; Fujiki, K.; Ishikawa, N.; Shigenaga, Y.; Baba, A., 1999:
BQ788, an endothelin ET(B) receptor antagonist, attenuates stab wound injury-induced reactive astrocytes in rat brain

Rogers, J., 1977:
BQA policy on medical care evaluation studies, JCAH policy on PSRO MCEs, AMRA response to reimbursement transmittal

Järvinen, S.H., 1991 :
BRACS--a method for cephalometric diagnosis and orthodontic treatment planning. Biometric radiographic analysis of the craniofacial skeleton

Feng-Quan, X.; Tao, Y.; Yong, H., 2016:
Advances in researches of balantidiosis

Nenov, V.I.; Buxey, F.; Yamaguchi, Y., 1999:
BRAVO/TeleTrend: a comprehensive WWW-based neuromonitoring system for the neurosurgery ICU

Anonymous, 1996:
BRC criteria revised

Lancaster; Carney; Futreal, 1997:
BRCA 1 and 2--A Genetic Link to Familial Breast and Ovarian Cancer

Engman, M.L.; Pinkham, C.A., 1995:
BRCA 1, BRCA 2 models

Goelen, G.; Rigo, A.; Bonduelle, M.; De Grève, J., 2000:
BRCA 1/2 gene mutation testing-based cancer prevention and the moral concerns of different types of patients

Zimmerman, V.L., 2002:
BRCA gene mutations and cancer

Healy, B., 1997:
BRCA genes--bookmaking, fortunetelling, and medical care

Foulkes, W.D.; Wong, N.; Brunet, J.S.; Narod, S.A., 1998:
BRCA mutations and survival in breast cancer

Robson, M.; Gilewski, T.; Haas, B.; Levin, D.; Borgen, P.; Rajan, P.; Hirschaut, Y.; Pressman, P.; Rosen, P.P.; Lesser, M.L.; Norton, L.; Offit, K., 1998:
BRCA-associated breast cancer in young women

Anonymous, 1998:
BRCA1 (breast cancer type 1). Tumor suppressor gene

Menczer, J.; Theodor, L.; Friedman, E., 1997:
BRCA1 185delAG mutation in a non-Ashkenazi Jewish woman with early-onset breast and ovarian cancer

Scholl, T.; Pyne, M.T.; Russo, D.; Ward, B.E., 1999:
BRCA1 IVS16+6T-->C is a deleterious mutation that creates an aberrant transcript by activating a cryptic splice donor site

Johnson, N.C.; Kruk, P.A., 2002:
BRCA1 Zinc RING Finger Domain Disruption Alters Caspase Response in Ovarian Surface Epithelial Cells

Fukutomi; Ushijima; Inoue; Akashi-Tanaka; Nanasawa; Tsuda, 2000:
BRCA1 and BRCA2 Germline Mutations in Japanese with Hereditary Breast Cancer Families

Bishop, D.T., 2000:
BRCA1 and BRCA2 and breast cancer incidence: a review

Farghaly, S.A., 1998:
BRCA1 and BRCA2 gene mutations in hereditary and sporadic ovarian cancer and the clinical implications

Fasouliotis, S.J.; Schenker, J.G., 2000:
BRCA1 and BRCA2 gene mutations: decision-making dilemmas concerning testing and management

Palmieri, G.; Palomba, G.; Cossu, A.; Pisano, M.; Dedola, M.F.; Sarobba, M.G.; Farris, A.; Olmeo, N.; Contu, A.; Pasca, A.; Satta, M.P.; Persico, I.; Carboni, A.A.; Cossu-Rocca, P.; Contini, M.; Mangion, J.; Stratton, M.R.; Tanda, F., 2002:
BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling

Saxena, S.; Szabo, C.I.; Chopin, S.; Barjhoux, L.; Sinilnikova, O.; Lenoir, G.; Goldgar, D.E.; Bhatanager, D., 2002:
BRCA1 and BRCA2 in Indian breast cancer patients

Lee, W.H.; Boyer, T.G., 2002:
BRCA1 and BRCA2 in breast cancer

Garvin, A.M.; Attenhofer-Haner, M.; Scott, R.J., 1998:
BRCA1 and BRCA2 mutation analysis in 86 early onset breast/ovarian cancer patients

Shih, H.A.; Couch, F.J.; Nathanson, K.L.; Blackwood, M.Anne.; Rebbeck, T.R.; Armstrong, K.A.; Calzone, K.; Stopfer, J.; Seal, S.; Stratton, M.R.; Weber, B.L., 2002:
BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic

Schubert, E.L.; Mefford, H.C.; Dann, J.L.; Argonza, R.H.; Hull, J.; King, M.C., 1997:
BRCA1 and BRCA2 mutations in Ashkenazi Jewish families with breast and ovarian cancer

Sibille-Hoang, C.; Froment, O.; Joos de ter Beerst, A.; Lepiece, V.; Huberlant, G.; Blauwaert, G.; Vindevoghel, A.; Canon, J.L.; Gillerot, Y., 2000:
BRCA1 and BRCA2 mutations in Belgian families with a history of breast and/or ovarian cancer

Tereschenko, I.V.; Basham, V.M.; Ponder, B.A.J.; Pharoah, P.D.P., 2002:
BRCA1 and BRCA2 mutations in Russian familial breast cancer

Basham, V.M.; Lipscombe, J.M.; Ward, J.M.; Gayther, S.A.; Ponder, B.A.J.; Easton, D.F.; Pharoah, P.D.P., 2002:
BRCA1 and BRCA2 mutations in a population-based study of male breast cancer

Shih, H.A.; Nathanson, K.L.; Seal, S.; Collins, N.; Stratton, M.R.; Rebbeck, T.R.; Weber, B.L., 2000:
BRCA1 and BRCA2 mutations in breast cancer families with multiple primary cancers

Ottini, L.; D'Amico, C.; Noviello, C.; Lauro, S.; Lalle, M.; Fornarini, G.; Colantuoni, O.A.; Pizzi, C.; Cortesi, E.; Carlini, S.; Guadagni, F.; Bianco, A.R.; Frati, L.; Contegiacomo, A.; Mariani-Costantini, R., 2000:
BRCA1 and BRCA2 mutations in central and southern Italian patients

Koul, A..; Malander, S..; Loman, N..; Pejovic, T..; Heim, S..; Willen, R..; Johannsson, O..; Olsson, H..; Ridderheim, M..; Borg Å, Å.., 2001:
BRCA1 and BRCA2 mutations in ovarian cancer: Covariation with specific cytogenetic features

Bernard-Gallon, D.J.; Déchelotte, P.; Vissac, C.; Aunoble, B.; Cravello, L.; Malpuech, G.; Bignon, Y.J., 2001:
BRCA1 and BRCA2 protein expressions in an ovotestis of a 46, XX true hermaphrodite

Duncan, J.A.; Reeves, J.R.; Cooke, T.G., 1999:
BRCA1 and BRCA2 proteins: roles in health and disease

Zhi, X.; Szabo, C.; Chopin, S.; Suter, N.; Wang, Q-Sheng.; Ostrander, E.A.; Sinilnikova, O.M.; Lenoir, G.M.; Goldgar, D.; Shi, Y-Rong., 2002:
BRCA1 and BRCA2 sequence variants in Chinese breast cancer families

Dagan, E.; Gershoni-Baruch, R., 1998:
BRCA1 and BRCA2--breast cancer susceptibility genes

Burke, W.; Press, N.; Pinsky, L., 1999:
BRCA1 and BRCA2: a small part of the puzzle

Scherneck, S.; Hofmann, W., 1999:
BRCA1 and BRCA2: mutations and other genetic changes--practical relevance

Foulkes, W.D., 1998:
BRCA1 and BRCA2: penetrating the clinical arena

Lee, E.Y-H.P. , 2002:
BRCA1 and Chk1 in G2/M checkpoint: a new order of regulation

Fearon, E.R., 2000:
BRCA1 and E-cadherin promoter hypermethylation and gene inactivation in cancer-association or mechanism?

Larsen, C.J., 2001:
BRCA1 and cancer: a new lead

Eisinger, F.; Noguès, C.; Birnbaum, D.; Jacquemier, J.; Sobol, H., 1998:
BRCA1 and medullary breast cancer

Gardner, K.; Liu, E.T., 2001:
BRCA1 function in T lymphocytes: a cellular specificity of a different kind

Ding, X.; Lang, J., 2002:
BRCA1 gene mutations in early-onset breast cancer

Vijg, J.; Perls, T.; Franceschi, C.; van Orsouw, N.J., 2002:
BRCA1 gene sequence variation in centenarians

Crosbie, A.; Brewer, C.; Campbell, K.; MacKay, J., 1999:
BRCA1 gene testing for breast and ovarian cancer in one family

Hadjisavvas, A.; Neuhausen, S.L.; Hoffman, M.D.; Adamou, A.; Newbold, R.F.; Kyriacou, K.C.; Christodoulou, C.G., 2002:
BRCA1 germline mutations in Cypriot breast cancer patients from 26 families with family history

Valarmathi, M.T.; A, A.; Deo, S.S.V.; Shukla, N.K.; Das, S.N., 2002:
BRCA1 germline mutations in Indian familial breast cancer

Frankish, H., 2001:
BRCA1 has a pivotal role in repairing DNA

Aprelikova, O.; Pace, A.J.; Fang, B.; Koller, B.H.; Liu, E.T., 2001:
BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells

Meng, Q.H.; Yuan, R.Q.; Goldberg, I.D.; Rosen, E.M.; Fan, S.J., 2003:
BRCA1 is differentially expressed in human tumor cells

Bernard-Gallon, D.J.; Peffault de Latour, M.; D.O.iveira, F.; Rio, P.; Hizel, C.; Favy, D.; Bignon, Y.J., 1998:
BRCA1 is localized in ductal secretions of normal breast tissues: Detection by antibodies raised against the amino terminus of BRCA1 (K-18)

Konstantopoulou, I.; Kroupis, C.; Ladopoulou, A.; Pantazidis, A.; Boumba, D.; Lianidou, E.S.; Petersen, M.B.; Florentin, L.; Chiotellis, E.; Nounesis, G.; Efstathiou, E.; Skarlos, D.; Tsionou, C.; Fountzilas, G.; Yannoukakos, D., 2000:
BRCA1 mutation analysis in breast/ovarian cancer families from Greece

Yamashita, Y.; Sagawa, T.; Fujimoto, T.; Sugawara, T.; Yamada, H.; Hoshi, N.; Sakuragi, N.; Ishioka, C.; Fujimoto, S., 2000:
BRCA1 mutation testing for Japanese patients with ovarian cancer in breast cancer screening

Petty, E.M.; Killeen, A.A., 1997:
BRCA1 mutation testing: controversies and challenges

Whitmore, S.E., 1997:
BRCA1 mutations and survival in women with ovarian cancer

Shushan, A.; Abeliovich, D.; Peretz, T.; Weinberg, N.; Paltiel, O., 1997:
BRCA1 mutations in women with ovarian cancer

Struewing, J.P.; Tarone, R.E.; Brody, L.C.; Li, F.P.; Boice, J.D., 1996:
BRCA1 mutations in young women with breast cancer

Kumar, A.; Knott, C.; Kuus-Reichel, K.; Saedi, M.S., 2000:
BRCA1 partially reverses the transforming activity of the ras oncogene

Xue, L.; Jian-Rong, D.; Yun-Tian, X., 2018:
Advances in researches of biogenic molluscicides

Arver, B.; Claro, A.; Langerød, A.; Børresen-Dale, A.L.; Lindblom, A., 1999:
BRCA1 screening in patients with a family history of breast or ovarian cancer

Stoppa-Lyonnet, D.; Laurent-Puig, P.; Essioux, L.; Pagès, S.; Ithier, G.; Ligot, L.; Fourquet, A.; Salmon, R.J.; Clough, K.B.; Pouillart, P.; Bonaïti-Pellié, C.; Thomas, G., 1997:
BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group

Schneider, K.A.; Kieffer, S.A.; Patenaude, A.F., 2003:
BRCA1 testing and informed consent in a woman with mild retardation

Couch, F.J.; Hartmann, L.C., 1998:
BRCA1 testing--advances and retreats

Takimoto, R.; MacLachlan, T.K.; Dicker, D.T.; Niitsu, Y.; Mori, T.; el-Deiry, W.S., 2002:
BRCA1 transcriptionally regulates damaged DNA binding protein (DDB2) in the DNA repair response following UV-irradiation

Carter, R.F., 2001:
BRCA1, BRCA2 and breast cancer: a concise clinical review

Lynch, H.T.; Watson, P., 1998:
BRCA1, pathology, and survival

Collins, F.S., 1996:
BRCA1--lots of mutations, lots of dilemmas

Brodie, S.G.; Deng, C.X., 2001:
BRCA1-associated tumorigenesis: what have we learned from knockout mice?

Offit, K., 1996:
BRCA1. A new marker in the management of patients with breast cancer?

Eeles, R.; Kadouri, L., 2000:
BRCA1/2 carriers and endocrine risk modifiers

Chen, W.Y.; Garber, J.E.; Higham, S.; Schneider, K.A.; Davis, K.B.; Deffenbaugh, A.M.; Frank, T.S.; Gelman, R.S.; Li, F.P., 2002:
BRCA1/2 genetic testing in the community setting

Formenti, S.C.; Preston-Martin, S.; Haffty, B.G., 2000:
BRCA1/2 germline mutations: a marker for radioresistance or radiosensitivity?

Turner, B.C.; Glazer, P.M.; Haffty, B.G., 1999:
BRCA1/BRCA2 in breast-conserving therapy

Gilbert, F.; Dabney, M.K.; Diemer, K.; Ludwig, S.; Rosenthal, G.; Osborne, M.P., 1998:
BRCA1/BRCA2 mutations and breast cancer in Ashkenazi Jewish women

Paterson, J.W., 1998:
BRCA1: a review of structure and putative functions

Haber, D., 2000:
BRCA1: an emerging role in the cellular response to DNA damage

Ross, D.W., 1997:
BRCA1: genetic testing and hereditary breast and ovarian cancer

Reynolds, T., 2001:
BRCA1: lessons learned from the breast cancer gene

Singer, M.E.; Cebul, R.D., 1997:
BRCA1: to test or not to test, that is the question

Buller, R.E., 2000:
BRCA1: what do we know? What do we think we know? What do we really need to know?

Auranen, A.; Spurdle, A.B.; Chen, X.; Lipscombe, J.; Purdie, D.M.; Hopper, J.L.; Green, A.; Healey, C.S.; Redman, K.; Dunning, A.M.; Pharoah, P.D.; Easton, D.F.; Ponder, B.A.J.; Chenevix-Trench, G.; Novik, K.L., 2002:
BRCA2 Arg372Hispolymorphism and epithelial ovarian cancer risk

Orelli, B.J.; Bishop, D.K., 2001:
BRCA2 and homologous recombination

Boyd, J., 1996:
BRCA2 as a low-penetrance cancer gene

Qiao, Y.; Chen, P.; Shi, H.; Zhao, G.; Wu, D., 2002:
BRCA2 gene mutation detection in hereditary ovarian cancer tissues

Armakolas, A.; Ladopoulou, A.; Konstantopoulou, I.; Pararas, B.; Gomatos, I.P.; Kataki, A.; Konstadoulakis, M.M.; Stathopoulos, G.P.; Markopoulos, C.; Leandros, E.; Gogas, I.; Yannoukakos, D.; Androulakis, G., 2001:
BRCA2 gene mutations in Greek patients with familial breast cancer

Díez, O.; Cortés, J.; Domènech, M.; Pericay, C.; Brunet, J.; Alonso, C.; Baiget, M., 2000:
BRCA2 germ-line mutations in Spanish male breast cancer patients

Plaschke, J.; Commer, T.; Jacobi, C.; Schackert, H.K.; Chang-Claude, J., 2000:
BRCA2 germline mutations among early onset breast cancer patients unselected for family history of the disease

Kwiatkowska, E.; Teresiak, M.; Lamperska, K.M.; Karczewska, A.; Breborowicz, D.; Stawicka, M.; Godlewski, D.; Krzyzosiak, W.J.; Mackiewicz, A., 2001:
BRCA2 germline mutations in male breast cancer patients in the Polish population

Campos, B.; Diez, O.; Domènech, M.; Baena, M.; Pericay, C.; Balmaña, J.; del Rio, E.; Sanz, J.; Alonso, C.; Baiget, M., 2002:
BRCA2 mutation analysis of 87 Spanish breast/ovarian cancer families

Nelson, N.J., 1998:
BRCA2 research is on a fast track to the clinic

Schwab, M.; Claas, A.; Savelyeva, L., 2001:
BRCA2: a genetic risk factor for breast cancer

Boyd, J., 2001:
BRCA: the breast, ovarian, and other cancer genes

Berry, D.A.; Iversen, E.S.; Gudbjartsson, D.F.; Hiller, E.H.; Garber, J.E.; Peshkin, B.N.; Lerman, C.; Watson, P.; Lynch, H.T.; Hilsenbeck, S.G.; Rubinstein, W.S.; Hughes, K.S.; Parmigiani, G., 2002:
BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes

Schomburg, I.; Chang, A.; Schomburg, D., 2001:
BRENDA, enzyme data and metabolic information

Billard, C.; Livet, M.O.; Motte, J.; Vallée, L.; Gillet, P.; Galloux, A.; Piller, A.G.; Vol, S., 2001:
BREV: a new clinical scale for the evaluation of cognitive function in school-age and preschool-age children

Billard, C.; Vol, S.; Livet, M.O.; Motte, J.; Vallée, L.; Gillet, P.; Marquet, T., 2002:
BREV: a rapid clinical scale for cognitive function evaluation in preschool and school-age children

Billard, C.; Gillet, P.; Galloux, A.; Piller, A.G.; Livet, M.O.; Motte, J.; Vallée, L.; Vol, S., 2000:
BREV: an assessment battery for cognitive deficits in children 4 to 9 years old. Results of a normative study in 500 children

Kohlmann, T., 2002:
BRFSS and beyond: methodological quality of the measures from the Behavioral Risk Factor Surveillance System

Vincent, A.L.; Bradham, D.; Hoecherl, S.; McTague, D., 1994:
BRFSS-based survey of the Florida public on restaurant smoking

Anonymous, 1979:
BRH urges voluntary ultrasound standards

Reid; Kirkpatrick; Gizis; Liebert, 1999:
BRI 0021-0214: Another Surprise at the Bottom of the Main Sequence

Nam, K.Hee.; Li, J., 2002:
BRI1/BAK1, a receptor kinase pair mediating brassinosteroid signaling

Muelleman, R.L.; Feighny, K.M.; Bozard, C.C.; Bergin, L., 1995:
BRIDGE: a community-based advocacy program for battered women in the emergency department

Köhler, L.; Eklund, L., 2002:
BRIMHEALTH. A successful experience in Nordic-Baltic co-operation in public health training

Fabbri, G.; Maggioni, A.P., 2000:
BRING-UP 2: presentation of the study

Stokes, T., 2001:
BRInging light to hormone receptor activation

Llor, X.; Serfas, M.S.; Bie, W.; Vasioukhin, V.; Polonskaia, M.; Derry, J.; Abbott, C.M.; Tyner, A.L., 1999:
BRK/Sik expression in the gastrointestinal tract and in colon tumors

Okada, Y.; Yanagisawa, T.; Taira, N., 1993:
BRL 38227 (levcromakalim)-induced hyperpolarization reduces the sensitivity to Ca2+ of contractile elements in canine coronary artery

Yamada, K., 1993:
BRM and drug combination therapy of HIV carriers

Bredderman, P.J.; Wojcik, J.; Flake, D., 1987:
BRS Colleague MEDLINE end user training follow-up survey

Chung; Kim, 1990:
BRS analysis of supersymmetrized Zamolodchikov's spin-3 algebra

Kim; Park; Cho, 1988:
BRS analysis of the non-Abelian chiral Schwinger model

Burnel; Van der Rest-Jaspers M, 1988:
BRS and anti-BRS symmetries in the planar gauge

Maharana, 1988:
BRST Hamiltonian quantization of a spinless particle in a curved background

González; Pullin, 1990:
BRST analysis of 2+1 gravity

Itoh; Kunitomo; Ohta; Sakaguchi, 1993:
BRST analysis of physical states in a two-dimensional black hole

Chang; Soo, 1992:
BRST cohomology and invariants of four-dimensional gravity in Ashtekar variables

Shin; Kim; Kim; Park, 1992:
BRST formulation of Chern-Simons gauge theory coupled to matter fields

Chung; Kim, 1989:
BRST invariance of the N-string vertex at space-time dimension fewer than 26

Tzani, 1991:
BRST light-cone quantization of the bosonic string Lagrangian

Bastianelli; Ohta, 1994:
BRST operator for the large N=4 superconformal algebra

Allen, 1991:
BRST quantization and coadjoint orbit theories

Fukai, 1988:
BRST quantization of a local supersymmetric chiral boson-fermion system

Braga, 1995:
BRST quantization of anomalous gauge theories

Voruganti, 1989:
BRST quantization of the CP1 model with Chern-Simons term in 2+1 dimensions

Braga; Montani, 1994:
BRST quantization of the chiral Schwinger model in the extended field-antifield space

Lin; Ni, 1990:
BRST quantization of the extended supersymmetric spinning particle

Das; Maharana; Roy, 1989:
BRST quantization of the superstring in background fields

Chen, 1990:
BRST quantization of topological field theory

Hwang; Lee, 1993:
BRST quantization of vector and axial-vector gauge theory

Ashtekar; Mazur; Torre, 1987:
BRST structure of general relativity in terms of new variables

Lee; Yee, 1993:
BRST symmetry in the Schrödinger picture

Cho; Chung; Jeong; Lee; Kim, 1990:
BRST- and OSP(1/2)-invariant N-superstring vertex at space-time dimension fewer than 10

García; Vergara; Urrutia, 1995:
BRST-BFV method for nonstationary systems

Okumura, 1996:
BRST-invariant Lagrangian of spontaneously broken gauge theories in a noncommutative geometry

Ohta, 1988:
BRST-invariant N-superstring vertices

Kobayashi; Konno; Suzuki, 1991:
BRST-invariant nonplanar primitive operators in the open-bosonic-string theory

Batlle; Gomis; Roca, 1989 :
BRST-invariant path integral for a spinning relativistic particle

Kobayashi; Konno; Suzuki, 1988:
BRST-invariant tadpole calculation and diagrammatic formalism in the bosonic string

Shapiro; Thorn, 1987:
BRST-invariant transitions between closed and open strings

Gururangan, S.; McFarland, J.G.; Cines, D.B.; Skupski, D.; Bussel, J.B., 1998:
BRa (HPA-5b) incompatibility may cause thrombocytopenia in neonates of mothers with immune thrombocytopenic purpura

O'Brien, P., 1992:
BS (British Standards) 5750: the message for managers

Manzanares, M.C.; Franch, J.; Carvalho, P.; Belmonte, A.M.; Tusell, J.; Franch, B.; Fernandez, J.M.; Clèries, L.; Morenza, J.L., 2002:
BS-SEM evaluation of the tissular interactions between cortical bone and calcium-phosphate covered titanium implants

Lightfoot, G., 2000:
BSA recommended procedure

Williams, I.D., 1993:
BSAC guidelines on sensitivity testing

Anonymous, 1995:
BSACI Special Interest Group Report on Food Allergy and Intolerance. June 1992-September 1993

Kovac, C.R.; Emelyanov, A.; Singh, M.; Ashouian, N.; Birshtein, B.K., 2000:
BSAP (Pax5)-importin alpha 1 (Rch1) interaction identifies a nuclear localization sequence

Anonymous, 2002 :
BSAVA awards, 2002

Anonymous, 2001:
BSAVA's evidence to the dispensing review

Scott-Park, F., 2002:
BSAVA's position on electronic training devices for dogs and cats. British Small Animal Veterinary Association

Chen, W.; Wang, J.; Ma, Y.; Wang, Y.; Yang, J., 2018:
Advances in Researches on the Relations between miRNA-143/miRNA-145 and Colorectal Cancer

Dudding, N.; Sutton, J., 2002:
BSCC terminology conference, koilocytosis and mild dyskaryosis

Enders, M.; Fröhlich, E.; Hassler, D.; Kretzschmar, H., 2001:
BSE (bovine spongiform encephalopathy) and the new variant of Creutzfeldt-Jakob disease

Poser, S., 2002:
BSE - A cause for Creutzfeldt- Jakob disease?

Baylis, M.; Houston, F.; Kao, R.R.; McLean, A.R.; Hunter, N.; Gravenor, M.B., 2003:
BSE - a wolf in sheep's clothing?

Ehmann, J.L., 1993:
BSE Rap: intergenerational ties to save lives

Delamothe, T., 1996:
BSE agent: there may be even more trouble ahead

Collins, J.D., 1997:
BSE and British cattle exports

Whitworth, C.L., 2001:
BSE and dentistry

Laubenthal, H., 1997:
BSE and heparin and gelatin preparations

Fraser, H., 1998:
BSE and hindsight

Bol, P., 2001:
BSE and other prion diseases

Overgaauw, P.A., 2001:
BSE and pet food: is animal feed safe?

Done, J., 1996:
BSE and rabies policies: science or sophistry?

Groschup, M.H.; Stolze, A., 2002:
BSE and scrapie diagnosis in Germany

van 't Hooft, A.J.G., 2002:
BSE and species specificity

Brown, P., 2000:
BSE and transmission through blood

Salzberger, B.; Diehl, V.; Kurth, R., 2002:
BSE and vCJD. New infectious prion diseases

Jaumann, M.P., 2002:
BSE and vCJD. Relevance for the established ENT physician

Beale, A.J., 2001:
BSE and vCJD: what is the future?

Ferguson-Smith, M.A., 2001:
BSE and variant CJD. Assumption that BSE originated from scrapie in sheep led to misjudgment

Grant, H., 2001:
BSE and variant CJD. Humans can live with BSE so long as they do not eat brains

Tacke, V., 2001:
BSE as an organizational construction: a case study on the globalization of risk

Keith, N.W., 1995:
BSE compensation

Fricker, J., 2001:
BSE crisis--transmission through blood transfusions?

Anonymous, 1999:
BSE epidemic continues to decline

McGregor, A., 1996:
BSE fears stir the Swiss

Simmons, M.M.; Harris, P.; Jeffrey, M.; Meek, S.C.; Blamire, I.W.; Wells, G.A., 1996:
BSE in Great Britain: consistency of the neurohistopathological findings in two random annual samples of clinically suspect cases

Donnelly, C.A.; Santos, R.; Ramos, M.; Galo, A.; Simas, J.P., 2000:
BSE in Portugal: anticipating the decline of an epidemic

Fleetwood, A., 2002:
BSE in cattle born after July 31, 1996, in Great Britain

Anonymous, 2001:
BSE in companion animals

Balter, M., 2002:
BSE in sheep? Humiliated lab fights to save face

Abbasi, K., 2000:
BSE inquiry plays down errors

Ashraf, H., 2000:
BSE inquiry uncovers "a peculiarly British disaster"

Dillner, L., 1996:
BSE linked to new variant of CJD in humans

Anonymous, 1996:
BSE meeting at CDC

Podger, G., 2001:
BSE report

Anonymous, 1996:
BSE research results suggest 'enhanced risk' of maternal transmission

Marwick, C., 1997:
BSE sets agenda for imported gelatin

Römer, D.A.; Overgaauw, P.A., 1996:
BSE symposium 19th World Buiatrics Congress Edinburgh. England on BSE regulations

Urlings, B.; Bianchi, A., 2001:
BSE testing in the Netherlands

Urlings, B., 2001:
BSE tests are negative in 17,000 cows

Williams, N., 2001:
BSE uncertainties drag on

Zenner, H-Peter., 2002:
BSE virus in the tonsils?

Riemer, C.; Simon, D.; Neidhold, S.; Schultz, J.; Schwarz, A.; Baier, M., 2002:
BSE, scrapie, and vCJD: infectious neurodegenerative diseases

Danner, K., 1993:
BSE--a risk for man through pharmaceutical products? Position and politics of the German pharmaceutical industry

Anonymous, 2002:
BSE--bovine spongiform encephalopathy & Creutzfeldt-Jakob disease

Anonymous, 1996:
BSE--bovine spongiform encephalopathy ('mad cow disease')

Troeger, K., 2002:
BSE--consequences for slaughtering, cutting and employer's protection

Wiemer, U., 2002:
BSE--present and future legal requirements

Paukstadt, W., 2001:
BSE-cattle in Germany. Must we soon also count on vCJK patients?

Matthews, B., 2001:
BSE/TSE risks associated with active pharmaceutical ingredients and starting materials: the situation in Europe and the global implications for healthcare manufacturers

Groschup, M.H.; Stolze, A.; Kramer, M., 2002:
BSE/TSE--the present epidemiologic and diagnostic situation

Anonymous, 1997:
BSE: SEAC statement on maternal transmission

Plum, J., 1997:
BSE: can we predict the future?

van Wuijckhuise, L.; Vellema, P.; Terbijhe, R.J., 2001:
BSE: clinical diagnosis and field experience

Hay, J.; Seal, D.V., 1996:
BSE: cow politics revisited

Heeschen, W.H., 2002:
BSE: milk and risk potential?

Brown, P., 1998:
BSE: the final resting place

Andreas, M.; Debong, B., 1996:
BSG accepts point value decline in ambulatory surgery for 1993 and 1994. Decisions of the Federal Social Court 7 February 1996--6 RKa 61/94 and 42/95

Blasingame, D., 1988:
BSI plan protects hospital employee, patients

Adler-Michaelson, P., 1996:
BSL/ACLS--historical development (basic life support/ advanced cardiac life support)

Wilkerson, J.B., 1998:
BSN education

Anonymous, 1983:
BSN offered at hospital nursing school through consortium agreement

Mattera, M.D., 2000:
BSN on your terms!

Hinzmann, C., 1996:
BSN students present research findings on complex health problems in poster session format

Anonymous, 1999:
BSN, master's enrollment fall

Christiansen, D., 1998:
BSN-seeker objects to repeating nursing courses

Petrusyte, M.; Rudokas, K.; Maneliene, Z.; Kiuduliene, E.; Butkus, V.; Janulaitis, A., 1993:
BSP1407I, a restriction endonuclease from Bacillus stearothermophilus, which recognizes novel palindromic sequence 5'-T decreases GTACA-3'

Henry, K., 1996:
BSS: tracking trends in sexual behavior

Jukes, T.H., 1994:
BST and milk production

Dean, S.P., 1994:
BST ban

Gloyd, J.S., 1993:
BST product labels--still FDA's call

Mignogna, G.; Pascarella, S.; Wechselberger, C.; Hinterleitner, C.; Mollay, C.; Amiconi, G.; Barra, D.; Kreil, G., 1996:
BSTI, a trypsin inhibitor from skin secretions of Bombina bombina related to protease inhibitors of nematodes

Donkin, F., 1984:
BScN by 2000: one nurse's perspective

Koizumi, M.; Kimura, K.; Toyota, T., 1995:
BT-PABA test

Fischer, S.; Kraft, W., 1993:
BT-PABA/xylose test in the cat?

Fontaniere, B.; Ranchere, D.; Michot, J.P.; Barfety-Michot, B.; Genna, L.; Charles, N.; Marechal, J.M.; Colombel, M., 2001:
BTA test (Bard test) and urinary cytology

Heino, A.; Aaltomaa, S.; Ala-Opas, M., 2000:
BTA test is superior to voided urine cytology in detecting malignant bladder tumours

Yoshida, C.; Igarashi, K., 1999:
BTB/POZ domain proteins in nuclear structure and DNA loop formation

Martin-Fardon, Rémi.; Weiss, F., 2002:
BTCP is a potent reinforcer in rats: comparison of behavior maintained on fixed- and progressive-ratio schedules

Watanabe, N.; Kurabayashi, M.; Shimomura, Y.; Kawai-Kowase, K.; Hoshino, Y.; Manabe, I.; Watanabe, M.; Aikawa, M.; Kuro-o, M.; Suzuki, T.; Yazaki, Y.; Nagai, R., 1999:
BTEB2, a Krüppel-like transcription factor, regulates expression of the SMemb/Nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene

Anonymous, 1999:
BTI 322. Anti-CD2 monoclonal antibody, Lo-CD2-a, monoclonal antibody Lo-CD2-a

Islam, T.C.; Brandén, L.J.; Kohn, D.B.; Islam, K.B.; Smith, C.I., 2000:
BTK mediated apoptosis, a possible mechanism for failure to generate high titer retroviral producer clones

Tao, L.; Boyd, M.; Gonye, G.; Malone, B.; Schwaber, J., 2000:
BTK mutations in patients with X-linked agammaglobulinemia: lack of correlation between presence of peripheral B lymphocytes and specific mutations

Vihinen, M.; Iwata, T.; Kinnon, C.; Kwan, S.P.; Ochs, H.D.; Vorechovský, I.; Smith, C.I., 1996:
BTKbase, mutation database for X-linked agammaglobulinemia (XLA)

Dickinson, K.; North, T.J.; Sills, S.; Anthony, D.M.; Lock, J.I.; Vowles, D.T.; Jones, R.B., 1998:
BTS 67 582 stimulates insulin secretion from perifused rat pancreatic islets

Kaye, P.; O'Sullivan, I., 2001:
BTS asthma guide

Anonymous, 1998:
BTS guidelines for the management of chronic obstructive pulmonary disease. The COPD Guidelines Group of the Standards of Care Committee of the BTS

Gould, I.M., 2002:
BTS guidelines on CAP. Community acquired pneumonia

Anonymous, 1998:
BTS recommendations to respiratory physicians for organising the care of patients with lung cancer. The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee

Reich, J.M., 1997:
BTS sarcoidosis study

Combes, R.D.; Earl, L.K., 1999:
BTS special symposium. In vitro toxicology--priorities for the year 2000. University of Surrey, 23 April 1998. Report of a symposium to discuss the BTS working party report on in vitro toxicology

Fielder, R.J.; Atterwill, C.K.; Anderson, D.; Boobis, A.R.; Botham, P.; Chamberlain, M.; Combes, R.; Duffy, P.A.; Lewis, R.W.; Lumley, C.E.; Kimber, I.; Newall, D.R., 1998:
BTS working party report on in vitro toxicology

Pfeffer, H.U.; Breuer, L., 2001:
BTX measurements with diffusive samplers in the vicinity of a cokery: comparison between ORSA-type samplers and pumped sampling

Zhu, K.; Xu, Y.; Zhong, J.; Chen, S.; Zeng, H., 2002:
BU-CTX(2) as conditioning regimen for allogeneic hematopoietic stem cell transplantation in sixty patients with leukemia

Ortman, R.A.; Holderbaum, D.; Qu, X.M.; Banerjee, S.; Haqqi, T.M., 1994:
BUB/BnJ (H-2q) is a TCR deletion mutant mouse strain (TCR V beta a, KJ16-) that is susceptible to type II collagen-induced arthritis

Torres, G., 1995:
BUCAST: another new antiviral

Okada, K.; Oguchi, N.; Shinohara, K.; Tamura, N.; Ishii, K.; Noguchi, Y.; Hayashi, S.; Yamamoto, H.; Takeichi, M.; Fujimoto, H.; Shirota, T.; Hayashi, T., 1998:
BUN, Bence Jones protein, and chromosomal aberrations predict survival in multiple myeloma

Howell, F., 1998:
BUPA and the tobacco industry. Chairperson of BUPA in Republic of Ireland is also chairperson of tobacco producer

Ferriman, 1999:
BUPA moves towards managed care

Goodman, R.E., 1996:
BUPA's discretionary recognition of treatment. Psychosexual medicine is no longer recognised for benefit purposes

Crompton, S., 1988:
BUPA: doing the NHS a favour?

Heid, O., 1997:
BURST excitation pulses

Yung, W.K., 1999:
BUdR radiosensitization in anaplastic astrocytoma

Alexander, L.L., 2000:
BV public policy: issues and challenges

Floore, T.G.; Dukes, J.C.; Cuda, J.P.; Schreiber, E.T.; Greer, M.J., 1998:
BVA 2 mosquito larvicide--a new surface oil larvicide for mosquito control

Beswick, W., 1993:
BVA congress

Beswick, W.; Blackburn, T.; Brancker, M.; Chandler, T.; Crooks, J.; Gunn, D.; Haxby, D.; Hellig, H.; Hoskin, B.; Linklater, K.; Parry, J.; Steele-Bodger, A.; Stockman, M.; Tandy, J.; Tavemor, D.; Taylor, A., 2002:
BVA governance. British Veterinary Association

Anonymous, 2002:
BVA's 'pivotal' role in planning new animal health controls. British Veterinary Associatio

Anonymous, 1993:
BVA/Kennel Club/International Sheepdog Society Eye Scheme: notes on procedure

Rutstein, R.P.; Corliss, D.A., 2000:
BVAT distance vs. near stereopsis screening of strabismus, strabismic amblyopia and refractive amblyopia; a prospective study of 68 patients

Lutz, S., 1987:
BVC trying to acquire Gateway in stock swap

Verberne, L.R., 2000:
BVD approach: vaccination and eradication

Verberne, L.R., 2000:
BVD control: about persistent shedders and "quiet" carriers

Stelwagen, J.; Dijkhuizen, A.A., 1998:
BVD outbreak can be costly: a case report

Nettleton, P.F.; Gunn, G., 2002:
BVD virus genotype 2 in British cattle

Depner, K.; Hübschle, O.J.; Liess, B., 1991:
BVD-virus infection in goats-experimental studies on transplacental transmissibility of the virus and its effect on reproduction

Thorp, B.; McMullin, P.F., 1998:
BVPA guidelines on antimicrobial resistance

Swanson, R.A.; Sharp, F.R., 1994:
BW619C89, a glutamate release inhibitor, protects against focal cerebral ischemic damage

Legrand, V.; Vrolix, M.; De Bruyne, B.; Wijns, W.; Heyndrickx, G.; De Scheerder, I.; Taeymans, Y.; Vrints, C.; Materne, P.; Benit, E.; Col, J.; Boland, J.; De Keyser, J.M.; Lafontaine, P.; Renkin, J., 1997:
BWGIC guidelines for training and quality control in adult interventional cardiology. Belgian Working Group of Invasive Cardiology

Elices, M.J., 2002:
BX-471 Berlex

Solleder, P.; Beller, K.D.; Linder, R., 1996:
BY963: a sonographic contrast medium

Xu, L., 2002:
BYY harmony learning, structural RPCL, and topological self-organizing on mixture models

Gstaiger, M.; Hovens, C.; Georgiev, O.; Knoepfel, L.; Schaffner, W., 1996:
BZLF1 (ZEBRA, Zta) protein of Epstein-Barr virus selected in a yeast one-hybrid system by binding to a consensus site in the IgH intronic enhancer: a role in immunoglobulin expression?

van Agen, B.; Maas, L.M.; Zwingmann, I.H.; Van Schooten, F.J.; Kleinjans, J.C., 1997:
B[a]P-DNA adduct formation and induction of human epithelial lung cell transformation

Liu; Olson; Yang; Gu; Lynch; Arko; List; Bartlett; Veal; Liu; Paulikas; Vandervoort, 1989:
Ba 4d core-level spectroscopy in the YBa2Cu3O6.9 high-Tc superconductor: Existence of a surface-shifted component

Jones; Dai; Gallagher, 1990:
Ba 6pjnfj' autoionizing series

Jaffe; Kachru; van Linden van den Heuvell HB; Gallagher, 1985:
Ba 6png, J=3 and J=5 autoionizing states

Yang; Schrott; Tsuei, 1990:
Ba core-level shift in x-ray photoemission spectroscopy on single-phase Y1-xPrxBa2Cu3O7 and YBa2Cu3O7-y compounds

Jahreiss; Huber, 1985:
Ba oscillator strengths from a laser-excited vapor

Yamane, H.; Sasaki, S.; Kubota, S.; Kajiwara, T.; Shimada, M., 2002:
Ba(14)Cu(2)In(4)N(7), a new subnitride with isolated nitridocuprate groups and indium clusters

Mestdagh; Meynadier; de Pujo P; Sublemontier; Visticot; Berlande; Cuvellier; Gustavsson; Suits; Lee, 1993:
Ba(6s6p P11,mj)-->Ba(6s6p P32,mj') Zeeman cross sections in single collisions with N2, O2, and H2

Turicnik, A.; Benkic, P.; Zemva, B., 2002:
Ba(SbF(6))(2).5XeF(2): first xenon(II) compound with barium. Synthesis, vibrational spectra, and crystal structure

McMahon; Degtyareva; Nelmes, 2000:
Ba-IV-type incommensurate crystal structure in group-V metals

Licheron; Gervais, 1993:
Ba2-xKxPb1-yBiyO4- delta : Layered oxides with insulating or conducting properties and possible superconducting properties

Cava; Batlogg; Fleming; Sunshine; Ramirez; Rietman; Zahurak; van Dover RB, 1988:
Ba2-xLaxYCu3O7+/- delta perovskite compounds: Crystal chemistry

Thomas; Orenstein; Rapkine; Capizzi; Millis; Bhatt; Schneemeyer; Waszczak, 1988:
Ba2YCu3O7- delta : Electrodynamics of crystals with high reflectivity

Wengert, S.; Willems, J.B.; Nesper, R., 2001:
Ba4Si3Br2: a double salt of barium bromide and barium silicide containing a novel cyclotrisilicide unit

Jeon; Liang; Chen; Croft; Ruckman; Di Marzio D; Hegde, 1990:
BaBiO3 and the effect of potassium substitution using photoemission

Vandamme, A.M., 1996:
BaEV is a relic from an ancient retrovirus that crossed species barriers

O'Connor, B.B.; Rockney, R.; Alario, A., 2002:
BaFá BaFá: a cross-cultural simulation experience for medical educators and trainees

Litt, H.I.; Brody, A.S., 2001:
BaSO4-loaded agarose: a construction material for multimodality imaging phantoms

Haig, A.J.; Harris, A.; Quint, D.J., 2001:
Baastrup's disease correlating with diffuse lumbar paraspinal atrophy: a case report

Babbitt, B., 1985:
Babbitt believes Arizona's AHCCCS program can serve as nation's indigent care model

Brenner, C.; Levin, K., 1999:
Babbling of an infant with a repaired cleft lip: a case study

Voisin, A.; Elliott, D.B.; Regan, D.; Ruth, G.H., 1997:
Babe Ruth: with vision like that, how could he hit the ball?

Morgan, F., 1998:
Babe the magnificent organ donor? The perils and promises surrounding xenotransplantation

Dwyer, J., 2001:
Babel, justice, and democracy: reflections on a shortage of interpreters at a public hospital

Giamarchi; Shastry, 1992:
Baber scattering and resistivity of a two-dimensional two-band model

Wehrhahn; Appel, 1986:
Baber scattering in strong magnetic fields: The effect of Landau quantization

Wen-Hua, L.; Peng, W., 2018:
Advances in research of stem cell therapy for human parasitic diseases: a review

Rugel, J., 2000:
Babes in arms. Juvenile access to guns in Minnesota

Pallarito, K., 1996:
Babes in managed care land. Provider-sponsored networks are stepping cautiously into risk contracting

Anonymous, 2002:
Babes of innocence

Steel, R.J., 2000:
Babesia and Ehrlichia seropositive horses temporarily imported into Australia

Goff, W.L.; Johnson, W.C.; Cluff, C.W., 1998:
Babesia bovis immunity. In vitro and in vivo evidence for IL-10 regulation of IFN-gamma and iNOS

Marsaudon, E.; Camenen, J.; Testou, D.; Bourrée, P.; Samson, P.; Luneau, F., 1995:
Babesia canis human babesiosis causing a 40-day anuria

Arai, S.; Tsuji, M.; Kim, S.J.; Nakade, T.; Kanno, Y.; Ishihara, C., 1998:
Babesia canis infection in canine-red blood cell-substituted SCID mice

L'Hostis, M.; Chauvin, A., 2000:
Babesia divergens in France: descriptive and analytical epidemiology

Irizarry-Rovira, A.R..; Stephens, J.; Christian, J.; Kjemtrup, A.; DeNicola, D.B..; Widmer, W.R..; Conrad, P.A.., 2002:
Babesia gibsoni infection in a dog from indiana

Burkot, T.R.; Schneider, B.S.; Pieniazek, N.J.; Happ, C.M.; Rutherford, J.S.; Slemenda, S.B.; Hoffmeister, E.; Maupin, G.O.; Zeidner, N.S., 2001:
Babesia microti and Borrelia bissettii transmission by Ixodes spinipalpis ticks among prairie voles, Microtus ochrogaster, in Colorado

Shen, Y.; Gao, J.; Xu, K.; Xue, L.; Zhang, Y.; Shi, B.; Li, D.; Wei, X.; Higuchi, S., 1998:
Babesiasis in Nanjing area, China

Smith, R.D.; Evans, D.E.; Martins, J.R.; Ceresér, V.H.; Correa, B.L.; Petraccia, C.; Cardozo, H.; Solari, M.A.; Nari, A., 2001:
Babesiosis (Babesia bovis) stability in unstable environments

Yin, H.; Lu, W.; Luo, J., 1998:
Babesiosis in China

Enemark, H.; Petersen, J.E., 1998:
Babesiosis in Denmark

Quick, R.E.; Herwaldt, B.L.; Thomford, J.W.; Garnett, M.E.; Eberhard, M.L.; Wilson, M.; Spach, D.H.; Dickerson, J.W.; Telford, S.R.; Steingart, K.R.; Pollock, R.; Persing, D.H.; Kobayashi, J.M.; Juranek, D.D.; Conrad, P.A., 1993:
Babesiosis in Washington State: a new species of Babesia?

López Jiménez, L., 1997:
Babesiosis in a splenectomized patient. Is it the first case in Spain?

Weiss, L.M., 2002:
Babesiosis in humans: a treatment review

Wiercińska-Drapało, A.; Grzeszczuk, A.; Panasiuk, A.; Prokopowicz, D., 1998:
Babesiosis-disease of humans and animals

Persing, D.H.; Conrad, P.A., 1995:
Babesiosis: new insights from phylogenetic analysis